Show simple item record

dc.creatorMarongiu, Francesco
dc.creatorBarcellona, Doris
dc.date.accessioned2020-11-11T21:00:57Z
dc.date.available2020-11-11T21:00:57Z
dc.date.issued2020-10-01
dc.identifier.issn2512-9465
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/4145
dc.identifier.urihttp://hdl.handle.net/20.500.12613/4163
dc.description.abstractWe have read with interest the review article by Bikdeli et al recently published in Thrombosis and Haemostasis on the priority in planning studies on the different anticoagulants in coronavirus disease 2019 (COVID-19) infection.[1] The authors describe the characteristics of both the anticoagulants available today and in the future. Antiplatelets drugs have been also considered. Surprisingly, fondaparinux (FPX) has reached a lower priority research mean (4.89) than unfractionated heparin (UFH) and low-molecular weight heparin (LMWH) at intermediate (7.82) or therapeutic (7.53) dosage for hospitalized ward and intensive care unit patients. We believe that properties of these drugs have been overlooked by the scientific panel of the Global COVID-19 Thrombosis Collaborative Group.
dc.format.extent3 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofCOVID-19 Research
dc.relation.haspartTH Open, Vol. 4, Issue 4
dc.relation.isreferencedbyGeorg Thieme Verlag KG
dc.rightsAttribution CC BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleFondaparinux: Should It Be Studied in Patients with COVID-19 Disease?
dc.typeText
dc.type.genreCorrespondence
dc.contributor.groupCenter for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine (Temple University)
dc.relation.doihttp://doi.org/10.1055/s-0040-1719232
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.temple.creatorBarcellona, Doris
refterms.dateFOA2020-11-11T21:00:57Z


Files in this item

Thumbnail
Name:
Barcellona-Correspondence-2020.pdf
Size:
105.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution CC BY
Except where otherwise noted, this item's license is described as Attribution CC BY